The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles
Open accessAbstract
Cellular hitchhiking leverages the use of circulatory cells to enhance the biological outcome of nanoparticle drug delivery systems, which often suffer from poor circulation time and limited targeting. Cellular hitchhiking utilizes the natural abilities of circulatory cells to: (i) navigate the vasculature while avoiding immune system clearance, (ii) remain relatively inert until needed and (iii) perform specific functions, including nutrient delivery to tissues, clearance of pathogens, and immune system surveillance. A variety of synthetic nanoparticles attempt to mimic these functional attributes of circulatory cells for drug delivery purposes. By combining the advantages of circulatory cells and synthetic nanoparticles, many advanced drug delivery systems have been developed that adopt the concept of cellular hitchhiking. Here, we review the development and specific applications of cellular hitchhiking-based drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
Sallusto, F., Geginat, J., & Lanzavecchia, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104702 · Cited by 3,067
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
Caplan, A. I. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21200 · Cited by 1,956
Xia, T., Kovochich, M., Brant, J., Hotze, M., Sempf, J., Oberley, T., Sioutas, C., Yeh, J. I., Wiesner, M. R., & Nel, A. E. (2006) · Nano Letters · doi:10.1021/nl061025k · Cited by 1,918
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
B lymphocytes: how they develop and function
LeBien, T. W., & Tedder, T. F. (2008) · Blood · doi:10.1182/blood-2008-02-078071 · Cited by 1,400
Platelet-Rich Plasma: From Basic Science to Clinical Applications
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009) · The American Journal of Sports Medicine · doi:10.1177/0363546509349921 · Cited by 1,323
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Self-citationParodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Cytotoxic T lymphocytes: all roads lead to death
Barry, M., & Bleackley, R. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri819 · Cited by 933
Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
Tacken, P. J., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2173 · Cited by 750
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Viguier, M., Lemaître, F., Verola, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 686
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
NK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
Xia, T., Kovochich, M., Liong, M., Zink, J. I., & Nel, A. E. (2008) · ACS Nano · doi:10.1021/nn700256c · Cited by 624
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Adhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Adoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
Dendritic Cell Vaccines for Cancer Immunotherapy
Timmerman, M., & Levy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.507 · Cited by 485
Drug delivery by red blood cells: vascular carriers designed by mother nature
Muzykantov, V. R. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003610633 · Cited by 399
Red blood cell-mimicking synthetic biomaterial particles
Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J., & Mitragotri, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907127106 · Cited by 374
Self-citationMechanisms Initiating Platelet Thrombus Formation
Ruggeri, Z. M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657598 · Cited by 363
Anselmo, A. C., Gupta, V., Zern, B. J., Pan, D., Zakrewsky, M., Muzykantov, V., & Mitragotri, S. (2013) · ACS Nano · doi:10.1021/nn404853z · Cited by 355
Self-citationBatrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 323
Murray, M. M., Spindler, K. P., Abreu, E., Muller, J. A., Nedder, A., Kelly, M., Frino, J., Zurakowski, D., Valenza, M., Snyder, B. D., et al. (2007) · Journal of Orthopaedic Research · doi:10.1002/jor.20282 · Cited by 321
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Pierigè, F., Serafini, S., Rossi, L., & Magnani, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.029 · Cited by 295
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 266
Red Blood Cells: A Neglected Compartment in Pharmacokinetics and Pharmacodynamics
Hinderling, P. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01329-2 · Cited by 250
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Wierecky, J., Müller, M. R., Wirths, S., Halder-Oehler, E., Dörfel, D., Schmidt, S. M., Häntschel, M., Brugger, W., Schröder, S., Horger, M. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3905 · Cited by 228
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors
Choi, J., Kim, H.-Y., Ju, E. J., Jung, J., Park, J., Chung, H.-K., Lee, J. S., Lee, J. S., Park, H. J., Song, S. Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.022 · Cited by 215
Carrier Erythrocytes: An Overview
Hamidi, M., & Tajerzadeh, H. (2003) · Drug Delivery · doi:10.1080/713840329 · Cited by 215
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Stephan, M. T., Stephan, S. B., Bak, P., Chen, J., & Irvine, D. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.029 · Cited by 209
A Macrophage−Nanozyme Delivery System for Parkinson's Disease
Batrakova, E. V., Li, S., Reynolds, A. D., Mosley, R. L., Bronich, T. K., Kabanov, A. V., & Gendelman, H. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700184b · Cited by 209
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes
Chambers, E., & Mitragotri, S. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.005 · Cited by 206
Self-citationSurface Functionalization of Living Cells with Multilayer Patches
Swiston, A. J., Cheng, C., Um, S. H., Irvine, D. J., Cohen, R. E., & Rubner, M. F. (2008) · Nano Letters · doi:10.1021/nl802404h · Cited by 204
Cell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks
Doshi, N., Swiston, A. J., Gilbert, J. B., Alcaraz, M. L., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2011) · Advanced Materials · doi:10.1002/adma.201004074 · Cited by 191
Self-citationMurciano, J.-C., Medinilla, S., Eslin, D., Atochina, E., Cines, D. B., & Muzykantov, V. R. (2003) · Nature Biotechnology · doi:10.1038/nbt846 · Cited by 190
Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
Engineering antigens for in situ erythrocyte binding induces T-cell deletion
Kontos, S., Kourtis, I. C., Dane, K. Y., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216353110 · Cited by 190
Yoon, J.-Y., Park, H.-Y., Kim, J.-H., & Kim, W.-S. (1996) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1996.0075 · Cited by 164
Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse
Choi, M.-R., Bardhan, R., Stanton-Maxey, K. J., Badve, S., Nakshatri, H., Stantz, K. M., Cao, N., Halas, N. J., & Clare, S. E. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-012-0029-9 · Cited by 154
Cole, C., Qiao, J., Kottke, T. J., Díaz, R. M., Ahmed, A. U., Sanchez-Perez, L. A., Brunn, G. J., Thompson, J., Chester, J. D., & Vile, R. G. (2005) · Nature Medicine · doi:10.1038/nm1297 · Cited by 148
Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood
Doshi, N., Orje, J. N., Molins, B., Smith, J. W., Mitragotri, S., & Ruggeri, Z. M. (2012) · Advanced Materials · doi:10.1002/adma.201200607 · Cited by 113
Self-citationBringing natural killer cells to the clinic: ex vivo manipulation
Childs, R. W., & Berg, M. (2013) · Hematology · doi:10.1182/asheducation-2013.1.234 · Cited by 110
Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy Studies
Kerkar, S. P., Sanchez-Perez, L. A., Yang, S., Borman, Z. A., Muranski, P. J., Ji, Y., Chinnasamy, D., Kaiser, A., Hinrichs, C. S., Klebanoff, C. A., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182187600 · Cited by 99
Zhao, Y., & Haney, M. J. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.s4-003 · Cited by 92
Freely Suspended Cellular “Backpacks” Lead to Cell Aggregate Self-Assembly
Swiston, A. J., Gilbert, J. B., Irvine, D. J., Cohen, R. E., & Rubner, M. F. (2010) · Biomacromolecules · doi:10.1021/bm100305h · Cited by 74
Bioactive Polyelectrolyte Multilayers: Hyaluronic Acid Mediated B Lymphocyte Adhesion
Vasconcellos, F. C., Swiston, A. J., Beppu, M. M., Cohen, R. E., & Rubner, M. F. (2010) · Biomacromolecules · doi:10.1021/bm100570r · Cited by 73
Cell surface negativity and the binding of positively charged particles
Weiss, L., & Zeigel, R. F. (1971) · Journal of Cellular Physiology · doi:10.1002/jcp.1040770208 · Cited by 70
Interpretation of protein adsorption phenomena onto functional microspheres
Yoon, J., Kim, J., & Kim, W.-S. (1998) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(98)00045-9 · Cited by 64
Fraternale, A., Casabianca, A., Orlandi, C., Cerasi, A., Chiarantini, L., Brandi, G., & Magnani, M. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00128-6 · Cited by 41
Ishida, T., Maeda, R., Ichihara, M., Mukai, Y., Motoki, Y., Manabe, Y., Irimura, K., & Kiwada, H. (2002) · PubMed · Cited by 35
Chiarantini, L., Argnani, R., Zucchini, S., Stevanato, L., Zabardi, P., Grossi, M., Magnani, M., & Manservigi, R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00181-8 · Cited by 33
Rb, M., Kirch, H. J., & DeLoach, J. R. (1996) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1996.tb00361.x · Cited by 16
(2007) · PubMed
Cited by
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Self-citationCell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
Liu, Y., Luo, J., Chen, X., Liu, W., & Chen, T. (2019) · Nano-Micro Letters · doi:10.1007/s40820-019-0330-9 · Cited by 408
Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 397
Self-citationImpact of particle elasticity on particle-based drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.007 · Cited by 385
Self-citationChemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
Li, M., Li, S., Zhou, H., Tang, X., Wu, Y., Jiang, W., Tian, Z., Zhou, X., Yang, X., & Wang, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-14963-0 · Cited by 300
Metadata
- Authors
- Anselmo, A. C., & Mitragotri, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 531-541
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2056014360
- Cited by
- 311
- References
- 76
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.